Showing results (1-10 of 181) with videos related to
Sort By:
Pageof 19
Clinical Pharmacology and Therapeutics|October 1, 1984
Single-dose ceftriaxone kinetics in liver insufficiencyK Stoeckel, H Tuerk, V Trueb, et al.Journal of Pharmaceutical Sciences|May 1, 1988
Protein binding of ceftriaxone in extravascular fluidsP J McNamara, V Trueb, K StoeckelBiochemical Pharmacology|September 15, 1990
Ceftriaxone binding to human serum albumin. Indirect displacement by probenecid and diazepamP J McNamara, V Trueb, K StoeckelEuropean Journal of Clinical Pharmacology|January 1, 1988
Effect of probenecid on the elimination and protein binding of ceftriaxoneK Stoeckel, V Trueb, U C Dubach, et al.European Journal of Clinical Pharmacology|January 1, 1983
Volume of distribution terms for a drug (ceftriaxone) exhibiting concentration-dependent protein binding. I. Theoretical considerationsP J McNamara, M Gibaldi, K StoeckelEuropean Journal of Clinical Pharmacology|January 1, 1983
Volume of distribution terms for a drug (ceftriaxone) exhibiting concentration-dependent protein binding. II. Physiological significanceP J McNamara, M Gibaldi, K StoeckelEuropean Journal of Clinical Pharmacology|January 1, 1982
Pharmacokinetics of ceftriaxone following intravenous administration of a 3 g doseP J McNamara, K Stoeckel, W H ZieglerAntimicrobial Agents and Chemotherapy|December 1, 1993
Bioavailability of syrup and tablet formulations of cefetamet pivoxilM P Ducharme, D J Edwards, P J McNamara, et al.Clinical Pharmacology and Therapeutics|May 1, 1983
Single-dose ceftriaxone kinetics in functionally anephric patientsK Stoeckel, P J McNamara, G Hoppe-Seyler, et al.British Journal of Clinical Pharmacology|February 1, 1985
Lack of effect of tenoxicam on glibornuride kinetics and responseK Stoeckel, V Trueb, U C Dubach, et al.Pageof 19